Status:
COMPLETED
Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Endometrial Cancer
Postmenopausal Bleeding
Eligibility:
FEMALE
40-69 years
Brief Summary
Endometrial cancer is the most common malignancy of the female genital tract in Hong Kong. The aim in the evaluation of PMB is to exclude underlying malignancy. Endometrial thickness (ET) measured by ...
Detailed Description
Endometrial cancer is the most common malignancy of the female genital tract in Hong Kong. It is estimated that around 10% of women experience postmenopausal bleeding. Around 90% of women with endomet...
Eligibility Criteria
Inclusion
- postmenopausal woman
- referrals for the symptom of PMB
Exclusion
- dementia
- mental retardation
Key Trial Info
Start Date :
June 3 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 26 2017
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT03330015
Start Date
June 3 2016
End Date
September 26 2017
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong